Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion (Part A)

NCT04555044 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Fatty Acid Deficiency (EFAD)

Interventions

DRUG: Clinolipid
DRUG: Intralipid

Sponsor

Baxter Healthcare Corporation